<div>Our family is begging for your help to save our precious three-year-old daughter, Harlow. We have been given a miraculous chance—thanks to the n-Lorem Foundation, a life-saving gene therapy has been developed just for her. This could be the answer to our prayers, the chance to stop this devastating disease in its tracks.

</div>

<div><br />

</div>

<div>But we are facing a heartbreaking reality. While the drug itself is provided for free by this extraordinary non-profit, the costs of administering it during the clinical trial phase are not fully covered by insurance. We had believed grants would help bridge the gap, but now we are left with an overwhelming, unexpected financial burden—one that reaches well into six figures.

</div>

<div><br />

</div>

<div>We are running out of time. In just sixty days, Harlow is scheduled to begin treatment at Rady Hospital in San Diego, and we simply cannot do this alone. We are desperate. We need your help.

</div>

<div><br />

</div>

<div>The FDA has approved Harlow’s clinical trial and IND (Investigational New Drug) application. Everything is in place except the financial means to make this happen. As an active-duty military family with three little ones, we uprooted our entire lives to California to give our daughter this chance. But now, we are at the final hurdle, and we cannot cross it without you.

</div>

<div><br />

</div>

<div>Without this groundbreaking treatment, this disease will take everything from Harlow. First, it will steal her ability to walk, then to crawl, then to eat, then to speak—until, eventually, it will take her life. I cannot, I will not, sit back and watch her light fade away. I cannot lose her.

</div>

<div><br />

</div>

<div>Who is Harlow?

</div>

<div><br />

</div>

<div>Harlow was diagnosed in July 2023 with TUBB4A leukodystrophy, a rare and terminal neurodegenerative disease. We started searching for answers when, at 18 months, she still wasn’t walking independently. An MRI showed she had less white matter in her brain than normal, and genetic testing confirmed our worst fear—TUBB4A-related leukodystrophy.

</div>

<div><br />

</div>

<div>Right now, the only limitation this disease has placed on her is that she cannot walk on her own—but she doesn’t let that stop her. She cruises and dances with her posterior walker, lighting up the world with her feisty, fearless spirit. She is sharp, funny, and overflowing with love. She adores her younger sister, Hope, and her big brother, Henry. She loves everything pink, the beach, animals, and giving the most heartfelt hugs that remind you—on even the darkest days—that pure goodness still exists.

</div>

<div><br />

</div>

<div>To know Harlow is to love her. And to love her is to fight for her.

</div>

<div><br />

</div>

<div>Please, we are asking with everything we have—help us save her. Share her story, donate if you can, and be part of the miracle that will let Harlow keep dancing, laughing, and living the full life she deserves.

</div>

<div><br />

</div>

<div>With hope and all the love in our hearts,

</div>

<div>Daphne and Luis

</div>

Jerilynn Dudley

Jeffrey Katz

Anonymous

Damian Pelaez

Matthew Flesch

Guissu Baier

Dee Dee Wolverton

Prashanthi Ravanavarapu Prashanthi Ravanavarapu

GoFundMe Team

Tammy Pham

Jozef Adato

Save Harlow - Help Her Access Life-Saving Gene Therapy

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Enter your donation forSave Harlow - Help Her Access Life-Saving Gene Therapy